91 related articles for article (PubMed ID: 7896018)
1. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat.
Dela Cadena RA; Stadnicki A; Uknis AB; Sartor RB; Kettner CA; Adam A; Colman RW
FASEB J; 1995 Mar; 9(5):446-52. PubMed ID: 7896018
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
[TBL] [Abstract][Full Text] [Related]
3. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.
Stadnicki A; DeLa Cadena RA; Sartor RB; Bender D; Kettner CA; Rath HC; Adam A; Colman RW
Dig Dis Sci; 1996 May; 41(5):912-20. PubMed ID: 8625762
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat.
Uknis AB; DeLa Cadena RA; Janardham R; Sartor RB; Whalley ET; Colman RW
Inflamm Res; 2001 Mar; 50(3):149-55. PubMed ID: 11339503
[TBL] [Abstract][Full Text] [Related]
5. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
[TBL] [Abstract][Full Text] [Related]
6. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.
DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW
Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642
[TBL] [Abstract][Full Text] [Related]
7. Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat.
Blais C; Couture R; Drapeau G; Colman RW; Adam A
Arthritis Rheum; 1997 Jul; 40(7):1327-33. PubMed ID: 9214434
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
[TBL] [Abstract][Full Text] [Related]
9. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis.
Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW
Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052
[TBL] [Abstract][Full Text] [Related]
10. Plasma and tissue kallikrein in arthritis and inflammatory bowel disease.
Colman RW
Immunopharmacology; 1999 Sep; 43(2-3):103-8. PubMed ID: 10596840
[TBL] [Abstract][Full Text] [Related]
11. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
[TBL] [Abstract][Full Text] [Related]
12. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
Arch Med Res; 2005; 36(1):87-95. PubMed ID: 15900628
[TBL] [Abstract][Full Text] [Related]
13. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
[TBL] [Abstract][Full Text] [Related]
15. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats.
Stadnicki A; Chao J; Stadnicka I; Van Tol E; Lin KF; Li F; Sartor RB; Colman RW
Am J Physiol; 1998 Oct; 275(4):G854-61. PubMed ID: 9756518
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
[TBL] [Abstract][Full Text] [Related]
17. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.
Fujimori Y; Nakamura T; Shimizu K; Yamamuro T; Wanaka K; Okamoto S; Katsuura Y
Agents Actions; 1993 May; 39(1-2):42-8. PubMed ID: 8285139
[TBL] [Abstract][Full Text] [Related]
18. Bacterial cell wall polymers (peptidoglycan-polysaccharide) cause reactivation of arthritis.
Lichtman SN; Bachmann S; Munoz SR; Schwab JH; Bender DE; Sartor RB; Lemasters JJ
Infect Immun; 1993 Nov; 61(11):4645-53. PubMed ID: 8406862
[TBL] [Abstract][Full Text] [Related]
19. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.
Janusz MJ; Eisenberg RA; Schwab JH
Inflammation; 1987 Mar; 11(1):73-85. PubMed ID: 3552978
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
